Journal
NATURE COMMUNICATIONS
Volume 12, Issue 1, Pages -Publisher
NATURE RESEARCH
DOI: 10.1038/s41467-020-20223-y
Keywords
-
Categories
Funding
- Cancer Research UK [C596/A10419, C596/A26855]
- Francis Crick Institute from Cancer Research UK [FC0010557]
- UK Medical Research Council [FC0010557]
- Wellcome Trust
- CRUK Beatson Institute from Cancer Research UK
- CRUK Career Development Fellowship [C53309/A19702/A17196]
- Core Services and Advanced Technologies at the Cancer Research UK Beatson Institute [C596/A17196]
Ask authors/readers for more resources
The study demonstrates that inhibition of PHGDH in the serine synthesis pathway, in conjunction with serine and glycine depletion, can inhibit one-carbon metabolism and cancer growth to enhance therapeutic efficacy. This treatment shows effectiveness against drug-resistant tumors in mice, although there are differences in the ATF4 response between in vitro and in vivo settings.
Many tumour cells show dependence on exogenous serine and dietary serine and glycine starvation can inhibit the growth of these cancers and extend survival in mice. However, numerous mechanisms promote resistance to this therapeutic approach, including enhanced expression of the de novo serine synthesis pathway (SSP) enzymes or activation of oncogenes that drive enhanced serine synthesis. Here we show that inhibition of PHGDH, the first step in the SSP, cooperates with serine and glycine depletion to inhibit one-carbon metabolism and cancer growth. In vitro, inhibition of PHGDH combined with serine starvation leads to a defect in global protein synthesis, which blocks the activation of an ATF-4 response and more broadly impacts the protective stress response to amino acid depletion. In vivo, the combination of diet and inhibitor shows therapeutic efficacy against tumours that are resistant to diet or drug alone, with evidence of reduced one-carbon availability. However, the defect in ATF4-response seen in vitro following complete depletion of available serine is not seen in mice, where dietary serine and glycine depletion and treatment with the PHGDH inhibitor lower but do not eliminate serine. Our results indicate that inhibition of PHGDH will augment the therapeutic efficacy of a serine depleted diet. Dietary serine and glycine starvation has emerged as a potential therapy for cancer. Here, the authors show that inhibition of PHGDH, which mediates the first step in the serine synthesis pathway, improves the therapeutic efficacy of serine depletion diet in mouse xenograft models.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available